These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23158528)

  • 1. Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults.
    deFilippi CR; de Lemos JA; Tkaczuk AT; Christenson RH; Carnethon MR; Siscovick DS; Gottdiener JS; Seliger SL
    J Am Coll Cardiol; 2012 Dec; 60(24):2539-47. PubMed ID: 23158528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
    Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
    JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
    Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C
    JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
    Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
    J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
    deFilippi CR; Christenson RH; Gottdiener JS; Kop WJ; Seliger SL
    J Am Coll Cardiol; 2010 Feb; 55(5):441-50. PubMed ID: 20117457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study).
    Puleo CW; Ayers CR; Garg S; Neeland IJ; Lewis AA; Pandey A; Drazner MH; de Lemos JA
    Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078
    [No Abstract]   [Full Text] [Related]  

  • 7. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study.
    Michos ED; Selvin E; Misialek JR; McEvoy JW; Ndumele CE; Folsom AR; Ballantyne CM; Lutsey PL
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Hyre Anderson A; Yang W; Christenson RH; deFilippi CR; Deo R; Dries DL; Go AS; He J; Kusek JW; Lash JP; Raj D; Rosas S; Wolf M; Zhang X; Shlipak MG; Feldman HI
    J Am Soc Nephrol; 2015 Apr; 26(4):946-56. PubMed ID: 25278510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
    Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Verma S; Vedin O; Iwata T; Brueckmann M; Packer M; Anker SD;
    JACC Heart Fail; 2022 Jul; 10(7):512-524. PubMed ID: 35670067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
    Berry JD; Chen H; Nambi V; Ambrosius WT; Ascher SB; Shlipak MG; Ix JH; Gupta R; Killeen A; Toto RD; Kitzman DW; Ballantyne CM; de Lemos JA
    Circulation; 2023 Jan; 147(4):310-323. PubMed ID: 36533535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
    Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
    Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
    Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.
    Nambi V; Liu X; Chambless LE; de Lemos JA; Virani SS; Agarwal S; Boerwinkle E; Hoogeveen RC; Aguilar D; Astor BC; Srinivas PR; Deswal A; Mosley TH; Coresh J; Folsom AR; Heiss G; Ballantyne CM
    Clin Chem; 2013 Dec; 59(12):1802-10. PubMed ID: 24036936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.
    Pokharel Y; Mouhanna F; Schneider ALC; Rawlings AM; Knopman DS; Nambi V; Virani SS; Hoogeveen RC; Alonso A; Heiss G; Coresh J; Mosley T; Gottesman R; Selvin E; Ballantyne C; Power MC
    J Am Geriatr Soc; 2019 Nov; 67(11):2353-2361. PubMed ID: 31359423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
    Jhund PS; Anand IS; Komajda M; Claggett BL; McKelvie RS; Zile MR; Carson PE; McMurray JJ
    Eur J Heart Fail; 2015 Aug; 17(8):809-17. PubMed ID: 25921853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
    Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
    Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
    J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.